Tumor News and Research

RSS

What is the function of micronutrients in COVID-19 recovery?

Researchers assessed the function of micronutrients and metabolites derived from gut microbiota in coronavirus disease 2019 (COVID-19) recovery.

18 Oct 2022

Researchers identify a new gene essential to colon cancer growth

Researchers at Mount Sinai's Tisch Cancer Institute have identified a new gene that is essential to colon cancer growth and found that inflammation in the external environment around the tumor can contribute to the growth of tumor cells.

17 Oct 2022

Genetic signature predicts tumor metastases and patient survival in clear cell kidney cancer

Among patients with kidney cancer, the activity of four specific genes in the cancer cells seems to be able to predict the risk of the tumor spreading and the patient's chances of survival.

17 Oct 2022

Novel drug target for triple-negative breast cancer discovered

Research led by Dr. Suresh Alahari, Professor of Biochemistry at LSU Health New Orleans' Schools of Medicine and Graduate Studies, reports a combination of a novel small inhibitory molecule and an FDA-approved chemotherapy drug suppresses the growth of triple-negative breast cancer cells synergistically.

17 Oct 2022

What is the impact of COVID-19 and organophosphates on cardiac health?

In a new study, researchers discussed the impacts of organophosphates (OP) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on cardiovascular (CVS) health.

17 Oct 2022

More frequent chest imaging may benefit certain colorectal cancer patients

Colorectal cancer patients with certain clinical characteristics may benefit from more frequent chest imaging to help identify and target cancer that has spread to the lungs, according to new research presented at the Scientific Forum of the American College of Surgeons (ACS) Clinical Congress 2022.

17 Oct 2022

Selective immunoglobulin A deficiency a risk factor for severe COVID-19

In a recent study published in The Journal of Allergy and Clinical Immunology, researchers in New Zealand gathered evidence to show that selective immunoglobulin A deficiency (sIgAD) is an understated risk factor for severe coronavirus disease 2019 (COVID-19).

17 Oct 2022

Researchers examine how fermented vegetables affect inflammation markers in women

Western females can consume 0.5 g of fermented vegetables each day for six weeks without experiencing any major side effects

16 Oct 2022

High TNF receptors levels could predict COVID-19 mortality and disease severity

High levels of TNFR might successfully predict the increased severity of COVID-19.

16 Oct 2022

Scientists reveal why cancers of the adrenal glands are more common among women

Why are cancers of the adrenal glands1 more common among women? Why are prognoses worse for them? A team of scientists led by a CNRS researcher answers these questions in an article published on 14 October 2022 in Science Advances.

14 Oct 2022

Amplification of venous thromboembolism risk by COVID-19 among malignancy patients

In a new study, researchers reported the mechanisms involved in COVID-19 coagulopathy and the significance of SARS-CoV-2 infections for cancer patients concerning outcomes, thromboembolic complication risks, and consequences of management strategies.

14 Oct 2022

Newly identified process keeps some immune cells on their toes

Cancer cells use an unusual mechanism to migrate into new tissue and form metastases there. The same process probably also keeps some immune cells on their toes.

14 Oct 2022

Omicron sublineage BA.2.75.2 largely resistant to several monoclonal antibody antiviral treatments

A study at Karolinska Institutet in Sweden shows that the coronavirus variant BA.2.75.2, an Omicron sublineage, largely evades neutralizing antibodies in the blood and is resistant to several monoclonal antibody antiviral treatments.

14 Oct 2022

Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance

A study led by researchers at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) has determined the role that fibroblasts, the cells that contribute to tissue formation, play in a tumor's ability to generate resistance to the most common biological treatment for HER2.

14 Oct 2022

Multi-center analysis shines light on invasive lobular carcinoma

A multi-center analysis of patients with invasive lobular carcinoma, or ILC - the second most common histological subtype of invasive breast cancer in the U.S. - showed that, despite its prevalence, ILC is detected later and has worse outcomes than the predominant subtype of invasive breast cancer, known as invasive ductal carcinoma (IDC), or no special type.

14 Oct 2022

Study reveals why viral infections are less frequent but more severe in individuals with Down syndrome

Study finds memory B cell clones harbor the capacity to adopt multiple and functionally different fates in COVID-19 patients

Researchers examined single clones of SARS-CoV-2-specific memory B cells to understand their adaptability and fate.

13 Oct 2022

Tumor News and Research

What is the function of micronutrients in COVID-19 recovery?

Researchers identify a new gene essential to colon cancer growth

Genetic signature predicts tumor metastases and patient survival in clear cell kidney cancer

Novel drug target for triple-negative breast cancer discovered

What is the impact of COVID-19 and organophosphates on cardiac health?

More frequent chest imaging may benefit certain colorectal cancer patients

Selective immunoglobulin A deficiency a risk factor for severe COVID-19

Researchers examine how fermented vegetables affect inflammation markers in women

High TNF receptors levels could predict COVID-19 mortality and disease severity

Scientists reveal why cancers of the adrenal glands are more common among women

Amplification of venous thromboembolism risk by COVID-19 among malignancy patients

Newly identified process keeps some immune cells on their toes

Omicron sublineage BA.2.75.2 largely resistant to several monoclonal antibody antiviral treatments

Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance

Multi-center analysis shines light on invasive lobular carcinoma

Study reveals why viral infections are less frequent but more severe in individuals with Down syndrome

Review on Panax ginseng therapeutic efficacy for COVID-19-associated neurological diseases

Associations of cardioprotective medications with COVID-19 outcomes

UNO-peptide-modified CCN shows promise for targeted delivery of TAM immunomodulatory agents

Study finds memory B cell clones harbor the capacity to adopt multiple and functionally different fates in COVID-19 patients

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News